Akari Therapeutics
Price & Volume
Stats
See more52W Range | $0.21-$1.73 |
Market Cap | $16.9M |
Shares Short | 69,172 |
Financials
See moreRevenue (12 Mos) | $0 |
Revenue Growth (YoY) | 0% |
Gross Profit (12 Mos) | $0 |
Diluted EPS | $0 |
News
See moreYahoo Finance • 20 hours ago
Akari Therapeutics Initiates GMP Manufacturing of AKTX-101 ADC Program to Support Phase 1 First-in-Human Clinical Trial
Yahoo Finance • 6 days ago
Akari Therapeutics Releases Virtual Investor “What This Means” Segment
Yahoo Finance • 12 days ago
European Equities Traded in the US as American Depositary Receipts Lower in Friday Trading; Shares Still Up This Week
Yahoo Finance • 15 days ago
European Equities Traded in the US as American Depositary Receipts Rise in Tuesday Trading
About
CEO | Mr. Abizer Gaslightwala |
Address | 22 Boston Wharf Road, Boston, MA, United States, 02210 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 8 |
